Type IV Collagen Antibody : Biotin

Référence OASB02744

Conditionnement : 0.2mg

Marque : Aviva Systems Biology

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Type IV Collagen Antibody : Biotin (OASB02744)

Datasheets/ManualsPrintable datasheet for Type IV Collagen Antibody : Biotin (OASB02744)
Product Info
Tested Species ReactivityHuman
Predicted Species ReactivityMouse, Rat, Canine, Chicken, Chinchilla, Equine, Guinea Pig, Japanese Macaque, Porcine, Rabbit, Sheep, Tree Shrew
Product FormatLiquid. Phosphate buffered saline containing 0.1% sodium azide
ClonalityPolyclonal
HostGoat
ConjugationBiotin
ApplicationEM, FC, ICC, IHC-F, IHC-P, IP, WB
Additional InformationDescription: Pooled antisera from goats hyperimmunized with type IV collagen; purified by affinity chromatography on type IV collagen covalently linked to agarose; reacts with conformational determinants on type IV collagen; cross-adsorbed against Collagen types I, II, III, V, and VI for minimal reactivity
Reconstitution and StorageStore at 2-8C
ImmunogenType IV collagen
Concentration0.4 mg/mL
SpecificityType IV Collagen
Gene SymbolCOL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6
Gene Full Namecollagen type IV alpha 1 chain
Alias SymbolsBSVD, BSVD1, RATOR, PADMAL, COL4A1s
NCBI Gene Id1282; 1284; 1285; 1286; 1287; 1288
Protein Namecollagen alpha-1(IV) chain
Description of TargetThis gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants.
Uniprot IDP02462, P08572, Q01955, P53420, P29400, Q14031
Protein Accession #NP_001290039.1
Nucleotide Accession #NM_001303110.1